Vanguard Group Inc Oramed Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $1.25 Million - $3.03 Million	-336,852 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $423,341 - $717,974	51,690 Added 18.13%	336,852 $2.92 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $1.63 Million - $3.73 Million	125,467 Added 78.57%	285,162 $4.07 Million
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $419,989 - $824,743	34,624 Added 27.68%	159,695 $3.51 Million
Q2 2021 Aug 13, 2021	BUY	$8.34 - $14.59 $1.04 Million - $1.82 Million	125,071 New	125,071 $1.67 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.